Clinical Trial Update: A Study to Evaluate Safety and Immunogenicity of 1 Booster Dose of 1790GAHB Vaccine in Healthy Adults Primed With 3 Doses of 1790GAHB Vaccine in Study H03_01TP Compared to 1 Vaccination of 1790GAHB in Either Subjects Who Received Placebo in the Same Study or naïve Subjects Not Part of H03_01TP Study [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update evaluating safety and immunogenicity of a booster dose of 1790GAHB vaccine in adults primed with 1790GAHB versus controls; complet…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dysentery Bacillary

Drugs mentioned

• 1790GAHB vaccine (1790GAHB)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Dysentery, Bacillary | Phase 1 | Status: COMPLETED | Results posted: 2019-03-07